BAX
$31.35
Baxter International
$.63
2.05%
BAX
Earnings Whisper ®
N/A
2nd Quarter June 2025
Consensus: $0.60
Revenue: N/A
Share
Watch
Guidance announcement made Thursday, May 1, 2025
Latest EPS
Thursday, May 1, 2025
What do you expect when BAX reports earnings?
Where is BAX's stock price going from here?
Analysts
Pivots
Resistance
$32.17
$31.53
$31.13
Support
$30.09
$29.45
$29.05
Description
Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care.